These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 31264793)

  • 21. Eculizumab therapy in adults with allogeneic hematopoietic cell transplant-associated thrombotic microangiopathy.
    Vasu S; Wu H; Satoskar A; Puto M; Roddy J; Blum W; Klisovic R; Andritsos L; Hofmeister C; Benson DM; Efebera Y; Jaglowski S; Penza S; Cohen D; Devine S; Cataland S
    Bone Marrow Transplant; 2016 Sep; 51(9):1241-4. PubMed ID: 27064689
    [No Abstract]   [Full Text] [Related]  

  • 22. Anti-neutrophil cytoplasmic antibody-associated vasculitis complicated by thrombotic microangiopathy with posterior reversible encephalopathy syndrome successfully treated with eculizumab: A case report.
    Kitamura F; Yamaguchi M; Nishimura M; Katsuno T; Ito M; Sugiyama H; Iwagaitsu S; Nobata H; Kinashi H; Ishimoto T; Banno S; Ito Y
    Mod Rheumatol Case Rep; 2022 Jun; 6(2):254-259. PubMed ID: 35425980
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sickle cell disease is a risk factor for transplant-associated thrombotic microangiopathy in children.
    Schoettler M; Stenger E; Spencer K; Lutterman D; Rumbika S; Jones J; Haight A; Parikh S; Qayed M; Watkins B; Krishnamurti L; Williams KM; Chonat S
    Blood Adv; 2023 May; 7(9):1784-1795. PubMed ID: 36075028
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Eculizumab treatment of thrombotic microangiopathy in a patient with ulcerative colitis.
    Øzbay LA
    Clin J Gastroenterol; 2020 Jun; 13(3):344-348. PubMed ID: 31612381
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Manifestations and Vascular Changes in Pediatric Transplantation-Associated Thrombotic Microangiopathy.
    Schoettler ML; Saldana BD; Berkenkamp L; Chonat S; Watkins B; Rotz SJ; Simons D; Graf E; Rossi C; Cheng J; Hammers YA; Rytting H; Williams KM
    Transplant Cell Ther; 2023 Jan; 29(1):45.e1-45.e8. PubMed ID: 36202334
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Eculizumab for Severe Thrombotic Microangiopathy Secondary to Surgical Invasive Stress and Bleeding.
    Fujita Y; Terashita M; Yazawa M; Yamasaki Y; Imamura T; Kibayashi J; Sawai T; Hidaka Y; Ohtani K; Inoue N; Shibagaki Y
    Intern Med; 2020; 59(1):93-99. PubMed ID: 31902910
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transplant-associated thrombotic microangiopathy: Incidence, prognostic factors, morbidity, and mortality in allogeneic hematopoietic cell transplantation.
    Gavriilaki E; Sakellari I; Batsis I; Mallouri D; Bousiou Z; Vardi A; Yannaki E; Constantinou V; Tsompanakou A; Vadikoliou C; Kaloyannidis P; Bamihas G; Anagnostopoulos A
    Clin Transplant; 2018 Sep; 32(9):e13371. PubMed ID: 30080283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Complement-mediated thrombotic microangiopathy secondary to sepsis-induced disseminated intravascular coagulation successfully treated with eculizumab: A case report.
    Abe T; Sasaki A; Ueda T; Miyakawa Y; Ochiai H
    Medicine (Baltimore); 2017 Feb; 96(6):e6056. PubMed ID: 28178155
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Eculizumab as rescue therapy for lupus nephritis-related thrombotic microangiopathy].
    Fani FM; Patera A; Delsante M; Rossi GM; Manenti L; Landini S; Regolisti G; Fiaccadori E
    G Ital Nefrol; 2020 Jun; 37(3):. PubMed ID: 32530153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.
    Nusrat S; Davis H; MacDougall K; George JN; Nakamura R; Borogovac A
    J Intensive Care Med; 2024 May; 39(5):406-419. PubMed ID: 37990516
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebral vascular injury in transplant-associated thrombotic microangiopathy.
    Sabulski A; Arcuri G; Szabo S; Care MM; Dandoy CE; Davies SM; Jodele S
    Blood Adv; 2022 Jul; 6(14):4310-4319. PubMed ID: 35877136
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of eculizumab in children with allogeneic haematopoietic stem cell transplantation associated thrombotic microangiopathy - a multicentre retrospective PDWP and IEWP EBMT study.
    Svec P; Elfeky R; Galimard JE; Higham CS; Dalissier A; Quigg TC; Bueno Sanchez D; Han Lum S; Faraci M; Cole T; Pichler H; Benítez-Carabante MI; Horakova J; Gonzalez-Vicent M; Yanir A; Fagioli F; Wölfl M; von der Weid N; Protheroe R; Krivan G; Speckmann C; James B; Avcin SL; Bertrand Y; Verna M; Riha P; Patrick K; Cesaro S; Kalwak K; Bierings M; Büchner J; Mellgren K; Prohászka Z; Neven B; Lankester A; Corbacioglu S
    Bone Marrow Transplant; 2023 Feb; 58(2):129-141. PubMed ID: 36333550
    [TBL] [Abstract][Full Text] [Related]  

  • 33. De novo thrombotic microangiopathy following simultaneous pancreas and kidney transplantation managed with eculizumab.
    Shochet L; Kanellis J; Simpson I; Ta J; Mulley W
    Nephrology (Carlton); 2017 Feb; 22 Suppl 1():23-27. PubMed ID: 28176480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe, persistent neurotoxicity after transplant-associated thrombotic microangiopathy in a pediatric patient despite treatment with eculizumab.
    Schoettler M; Duncan C; Lehmann L
    Pediatr Transplant; 2019 May; 23(3):e13381. PubMed ID: 30828947
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MASP2 inhibition by narsoplimab suppresses endotheliopathies characteristic of transplant-associated thrombotic microangiopathy: in vitro and ex vivo evidence.
    Elhadad S; Redmond D; Huang J; Tan A; Laurence J
    Clin Exp Immunol; 2023 Jul; 213(2):252-264. PubMed ID: 37191586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The use of eculizumab in Capnocytophaga canimorsus associated thrombotic microangiopathy: a case report.
    Bjørkto MH; Barratt-Due A; Nordøy I; Dörje C; Galteland E; Lind A; Hilli A; Aukrust P; Mjøen G
    BMC Infect Dis; 2021 Feb; 21(1):137. PubMed ID: 33526010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Eculizumab precision-dosing algorithm for thrombotic microangiopathy in children and young adults undergoing HSCT.
    Mizuno K; Dandoy CE; Teusink-Cross A; Davies SM; Vinks AA; Jodele S
    Blood Adv; 2022 Mar; 6(5):1454-1463. PubMed ID: 35008105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Eculizumab in Transplant-Associated Thrombotic Microangiopathy.
    Dhakal P; Giri S; Pathak R; Bhatt VR
    Clin Appl Thromb Hemost; 2017 Mar; 23(2):175-180. PubMed ID: 26259912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interferon-complement loop in transplant-associated thrombotic microangiopathy.
    Jodele S; Medvedovic M; Luebbering N; Chen J; Dandoy CE; Laskin BL; Davies SM
    Blood Adv; 2020 Mar; 4(6):1166-1177. PubMed ID: 32208488
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is complement blockade an acceptable therapeutic strategy for hematopoietic cell transplant-associated thrombotic microangiopathy?
    Dhakal P; Bhatt VR
    Bone Marrow Transplant; 2017 Mar; 52(3):352-356. PubMed ID: 27775697
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.